Delays Cost Cephalon TRO In Anti-Epilepsy Patent Suit

Law360, Los Angeles (February 10, 2012, 10:05 PM EST) -- A New Jersey federal judge on Thursday denied Cephalon Inc.’s request for a temporary restraining order blocking sales of Sun Pharmaceutical Industries Ltd.’s generic version of an anti-epilepsy drug, saying the Pennsylvania drugmaker’s delay in bringing the patent infringement suit weighed against early judicial intervention.

“[I]n light of the continued unwarranted delays in prosecuting this action, plaintiff has not demonstrated that it will suffer immediate and irreparable harm absent the entry of a temporary restraining order,” U.S. District Judge Freda L. Wolfson wrote in her order...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.